Delivery Order SPE2DB22D1202-SPE2DB24FVEG5

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,232.87, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of "FIRST-MOUTHWASH BLM SUSPENSION 119ML", a medical product, with a performance period running through May 2, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, with ID SPE2DB24D1034|SPE2DB24FWAR4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,313.21 firm fixed-price delivery order is for the supply of "FIRST-MOUTHWASH BLM SUSPENSION 119ML", a medical product, with a completion date of June 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,223.83 Firm Fixed Price Delivery Order is for the provision of "FIRST-MOUTHWASH BLM SUSPENSION 119ML" medical supplies. The contract has an ultimate completion date of October 23, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award is a delivery order valued at $1,855.20 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "FIRST-MOUTHWASH BLM SUSPENSION 119ML", a medical product, with an ultimate completion date of October 23, 2023. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with...
This federal contract award, valued at $1,187.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC enables the government to efficiently procure a comprehensive range of essential pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,103.12 Firm Fixed Price Delivery Order contract is for the supply of "FIRST-MOUTHWASH BLM SUSPENSION 119ML" and has an ultimate completion date of October 23, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, SPE2DB22D1202|SPE2DB24FVDA4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,008.37, is a Firm Fixed Price Delivery Order for the provision of "FIRST-MOUTHWASH BLM SUSPENSION 119ML" medical supplies. The contract does not have a set-aside designation, indicating it was open to full and open competition. Amerisourcebergen Drug...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,825.26 firm fixed-price delivery order is for "FIRST-MOUTHWASH BLM SUSPENSION 119ML", a pharmaceutical product, with a completion date of November 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $2,368.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of First-Mouthwash BLM Suspension 237ML, a medical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,965.63 firm fixed-price delivery order is for the procurement of "FIRST-MOUTHWASH BLM SUSPENSION 237ML" medical supplies. The contract has an ultimate completion date of June 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVEG5
    Delivery Order

This federal contract award, with ID SPE2DB22D1202|SPE2DB24FVEG5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,706.02, is for the delivery of a "FIRST-MOUTHWASH BLM SUSPENSION 119ML" product, with a completion date of June 21, 2024.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:08 AM